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ABSTRACT Solubility plays a major role in protein puriﬁcation, and has serious implications in many diseases. We studied the
effects of pH and mutations on protein solubility by calculating the transfer free energy from the condensed phase to the solution
phase. The condensed phase wasmodeled as an implicit solvent, with a dielectric constant lower than that of water. To account for
the effects of pH, the protonation states of titratable side chains were sampled by running constant-pH molecular dynamics
simulations. Conformations were then selected for calculations of the electrostatic solvation energy: once for the condensed phase,
and once for the solution phase. The average transfer free energy from the condensed phase to the solution phase was found to
predict reasonablywell the variations in solubility of ribonucleaseSaand insulinwith pH. This treatment of electrostatic contributions
combined with a similar approach for nonelectrostatic contributions led to a quantitative rationalization of the effects of point
mutations on the solubility of ribonuclease Sa. This study provides valuable insights into the physical basis of protein solubility.
INTRODUCTION
The ability of a protein to dissolve in aqueous solutions is an
important property. This ability is measured by the solubility,
i.e., the equilibrium concentration of the protein in the solu-
tion phase when a saturation amount of the protein is present.
Most biochemical experiments rely on this ability, such as
protein expression and puriﬁcation, high-resolution structural
determination, and quantitative binding assays. Low solu-
bility is found to enhance amyloid ﬁbril formation (1), and is
expected to play a major role in diseases associated with
protein aggregation. A number of techniques were proposed
to increase protein solubility. These include time-consuming
screening strategies for optimal solvent conditions (2,3), co-
expression with molecular chaperones (4), attachment of a
small protein (fusion tag) (5,6) or peptide (poly-Lys or poly-
Arg) (7) as a solubility enhancement tag, and rational mu-
tations of surface-exposed hydrophobic residues to polar
residues (8–10), as reviewed by Trevino et al. (11). In addi-
tion, charge mutations have been introduced to manipulate
the isoelectric point (pI), which is an important determinant
of protein solubility (12–15).
Although experimental techniques have led to improve-
ments in protein solubility, it is highly desirable to develop
theoretical methods for predicting protein relative and abso-
lute solubility. Such methods may be used directly to obtain
desired levels of solubility for particular proteins, and may
provide the necessary guidance for reﬁning experimental
techniques to achieve optimal solvent conditions for protein
solubility. Theoretical models were developed to predict
aqueous solubility for drug and druglike compounds (16–19),
but developments for proteins are still very limited. Of great
interest are methods that would predict how protein solubility
varies with solvent conditions. A ﬁrst step in that direction
was taken recently (20), and accounted for the effect of salt
concentrations on protein solubility by considering electro-
static interactions of salt ions with the charges and the low-
dielectric region of a protein in the solution phase, while
neglecting the impact of salts in the condensed phase.
Here we continue our efforts at quantitative predictions of
protein solubility. An important advance beyond the previous
study (20) involves a speciﬁc account of the condensed
phase. The chemical potential of a protein in the solution
phase can be written in the form
G
s ¼ Gs1 kBT lnC; (1)
where C is the protein concentration, kBT is the thermal
energy, and Gs is the chemical potential at a ‘‘standard’’
concentration (e.g., at C¼ 1 M). In the condensed phase, the
individual protein molecules do not mix, so there is no
concentration-dependent term as in Eq. 1, and the chemical
potential will be denoted as Gc. The solubility, S, is the
concentration at which Gs and Gc are equal. Hence
S ¼ exp½ðGs GcÞ=kBT: (2)
The difference Gs  Gc [ DGc/s can be viewed as the
free energy of transfer from the condensed phase to the so-
lution phase. The more favorable it is for a protein to transfer
from the condensed phase to the solution phase, the lower the
transfer free energy, and correspondingly the higher the sol-
ubility. We modeled the condensed phase as an implicit sol-
vent, and decomposed the transfer free energy DGc/s into
electrostatic and nonelectrostatic components:
DGc/s ¼ DGc/sel 1DGc/sne : (3)
The electrostatic component was obtained by solving the
Poisson-Boltzmann (PB) equation (21–31), and the non-
electrostatic component was obtained based on the solvent-
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accessible surface area (22,28,32–35). Using this approach,
we speciﬁcally investigated the effects of pH and point mu-
tations on the solubility of ribonuclease Sa, motivated by the
availability of experimental data by Pace et al. (10) and Shaw
et al. (14). As an independent test of our approach, the pH
dependence of the solubility of insulin (12,36,37) was also
calculated. To the best of our knowledge, this work marks the
ﬁrst time that the effects of pH and mutations on protein sol-
ubility were calculated. Our treatment of the condensed phase
may prove inspiring for developing models of other complex
environments, such as the crowded milieu inside cells.
To gain insights into the implicit model of the condensed
phase, we also calculated the transfer free energies, from oc-
tanol (an organic solvent) to water, of pentapeptides AcWL-
X-LL, where X is any of the 20 amino acids. Experimental
results for these transfer free energies are available from
Wimley et al. (38) Our parallel studies of protein solubility
and peptide transfer free energy clearly demonstrate that
these two properties can be calculated from very similar
approaches, and conﬁrm the expectation that the implicit
model for the condensed phase has a dielectric constant and
nonelectrostatic solvation parameters intermediate between
water and an organic solvent.
METHODS
Constant-pH molecular dynamics simulations of
RNase Sa and insulin
Starting from the x-ray structure of RNase Sa given by Protein Data Bank
entry 1rgg (chain A), missing hydrogen atoms were added by the LEAP
program in the AMBER package. Constant-pH molecular dynamics simu-
lations followed the protocol established by Mongan et al. (39), as im-
plemented in the AMBER package (40). At each pH, 400 cycles of energy
minimization preceded 1 ns of constant-pH equilibration. From the next 2 ns
of simulation, 100 snapshots (separated by 20 ps) were taken as represen-
tative conformations of the protein at the given pH, to be used for calculating
electrostatic solvation energies (described below). In the simulations, the
generalized Born model for the implicit solvent (with the ‘‘igb’’ variable set
to 2) was used, along with the modiﬁed parm99 force ﬁeld (41). The simu-
lation time step was 2 fs. The protonation states of titratable groups were
assigned by a Monte Carlo procedure, with one titratable group at every 5
time steps. Nonbonded interactions were evaluated with a 30-A˚ cutoff. The
monovalent salt concentration in the generalized Born model was 0.1 M, and
the temperature was set to 300 K.
Corresponding to experimental conditions (14), independent molecular
dynamics (MD) simulations at nine pH values were carried out to study the
effects of pH on the solubility of RNase Sa. The pH values were 2.3, 2.9, 3.6,
4.0, 4.5, 4.8, 5.0, 5.2, and 5.4. In total, 13 residues were titrated (Fig. 1 A).
These included 11 carboxyls (E14, D17, D25, D33, E41, E54, E74, E78,
D79, D84, and D93) and two histidines (H53 and H85). The N-terminals
and C-terminals and the side chain of the N-terminal residue (D1) were not
titrated because of the lack of this option in the AMBER package.
In addition, a constant-pH simulation was performed at pH 4.25, to study
the effects of point mutations at position 76 on the solubility of RNase Sa. On
each of the 100 snapshots taken, residue T76 was replaced with the LEAP
program by the 19 other types of amino acids. The new side chains were
energy-minimized in a vacuum, whereas the rest of the protein was ﬁxed.
Similarly, a constant-pH simulation was performed at pH 7, and mutations of
T76 to D, R, S, K, and A were created to compare against the experimental
data (10) on these mutations.
Constant-pH simulations of zinc-insulin were performed in a similar
fashion. A hexamer, which is the known oligomeric state of zinc-insulin in
solution, was constructed by symmetric operations listed in Protein Data
Bank entry 4ins. The hexamer consists of two trimers. With each trimer, a
zinc ion is coordinated to H10 of chain B from the three monomers and one
water molecule (Fig. 1 B). In each monomer, ﬁve residues were titrated: E4
and E17 of chain A, and H5, E13, and E21 of chain B. Simulations were
performed at pH 4.0, 4.5, 5.0, 5.5, 5.75, 6.25, 6.75, and 7.0 up to 1.5 ns, with
100 snapshots from the last 0.5 ns saved for calculating electrostatic solva-
tion energies.
MD simulations of pentapeptides
The 20 pentapeptides AcWL-X-LL were built with the LEAP program and
energy-minimized before MD simulations in a vacuum. During the simula-
tions, the attractive part of van der Waals interactions was turned off, to
generate expanded conformations. Protonation states were ﬁxed at those
FIGURE 1 (A) Structure of RNase Sa. Eleven carboxyl side chains, two
histidines, and residue T76 are labeled and displayed as red, cyan, and yellow
sticks, respectively. The N-terminal residue happens to be an aspartate. The
side chain of this residue was not titrated in the constant-pH simulations, and
is not shown here. (B) Structure of zinc-insulin hexamer. The two trimers are
shown in the foreground and background in green and gray, respectively. The
two zinc ions and the coordinating histidines and water molecules are shown.
In addition, the ﬁve titrated side chains of onemonomer are labeled and shown
as sticks.
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appropriate for pH 9 (with R and K protonated, and D, E, H, and the
C-terminal unprotonated). No cutoff for nonbonded interactions was im-
posed. The temperature was 300K. The simulation time step was 1 fs, and the
total simulation time was 45 ns. One hundred conformations from the last
1 ns were uniformly sampled for later use.
From these 100 conformations of each pentapeptide appropriate for pH 9,
corresponding conformations appropriate for pH 1 were generated by neu-
tralizing the C-terminal, and when X¼D, E, or H, adding a proton to the side
chain of the guest residue. Neutralization of the C-terminal was modeled by
reassigning partial charges of 0.4 to the two carboxyl O atoms, and mod-
ifying the charge of the carboxyl C atom to 0.5928 and those on the two Cd
atoms of the side chain of the C-terminal residue to0.2163. Conformations
of the groups undergoing charge reassignment upon pH change were opti-
mized by 5000 cycles of energy minimization.
Calculation of electrostatic solvation energies
The electrostatic free energy of a solute molecule inside an implicit solvent
can be separated into a Coulomb term and the solvation term:
Gel ¼ GCoul1Gsolv: (4)






where qi represents solute charges, rij represents intercharge distances, and ei
represents the solute dielectric constant.We calculated electrostatic solvation
energies by solving the PB equation; our default PB solver was the UHBD
program (23). Unless otherwise noted, the values of electrostatic solvation
energies are averages over 100 conformations, generated as described above.
Following earlier work (25,29), the dielectric boundary between the solute
low dielectric and the solvent high dielectric was set to the solute van der
Waals surface. When a protein was in the solution phase or when a peptide
was dissolved in water, the solvent dielectric constant was set to 78.5. For the
condensed phase (or using octanol as solvent), a range of solvent dielectric
constants centering around 55 (or 15) was tested. Each solvent dielectric
constant was used in combination with a solute dielectric constant of 4. Note
that for a ﬁxed solute conformation, the Coulomb term is the same when the
solute molecule is in either the solution or the condensed phase. Therefore,
only the solvation term contributes to the transfer free energy DGc/s.
For modeling the effects of pH on the solubility of RNase Sa and insulin,
the solution of the PB equation started with a coarse grid with dimensions of
100 3 100 3 100 and a spacing of 1.5 A˚, followed by a ﬁne grid with
dimensions of 1403 1403 140 and a spacing of 0.5 A˚, both centered at the
center of the protein. For both proteins, the ionic strength was 0.1 M. For
modeling the effects of point mutations at position 76 of RNase Sa, the di-
mensions of both the coarse and ﬁne grids were increased to 200 3 200 3
200. We added a second ﬁne grid centered on Cb of residue 76, with di-
mensions of 140 3 140 3 140 and a spacing of 0.25 A˚. The ionic strength
was increased to 1.1 M. All calculations on the pentapeptides used a coarse
grid with dimensions of 403 403 40 and a spacing of 1.5 A˚, followed by a
ﬁne grid with dimensions of 80 3 80 3 80 and a spacing of 0.4 A˚ (both
centered at the peptide center). The ionic strength was 0.06 M.
To gain further insights into the condensed phase, we modeled the con-
densed phase of RNase Sa as a crystalline array of monomers. In the crystal
structure of RNase Sa, each unit cell contained eight monomers. We repli-
cated the unit cell in three dimensions (Fig. 2 A). The electrostatic solvation
free energy of a single monomer was calculated in the background of the
crystalline replicas. The single monomer and all its replicas were assigned a
dielectric constant of 4, and the rest of space was assigned the dielectric
constant of water (i.e., 78.5). Because we were interested in the electrostatic
solvation energy of a single monomer, only that monomer was charged (i.e.,
the charges on all the replicas were zeroed out; these replicas only served to
modify the dielectric function in the environment outside the single mono-
mer). Let this electrostatic solvation energy be Gcsolv: We then asked: if the
inhomogeneous dielectric environment, consisting of the low-dielectric
replicas embedded in the high-dielectric solvent, was mimicked by a uniform
dielectric medium, what would the optimal dielectric constant be? We an-
swered this question by reproducing the value of Gcsolv when the single
monomer was placed in a uniform dielectric medium with dielectric constant
ec (Fig. 2 B), and the value of ec was adjusted. In the calculation inside either
the inhomogeneous dielectric environment or the uniform dielectric medium,
the dielectric constant of the single monomer was maintained at 4.
The value ofGcsolv in principle involves an inﬁnite number of replicas. We
determined Gcsolv by including more and more replicas around the single
monomer. The plateau value, after a sufﬁcient number of replicas was in-
cluded, was taken to beGcsolv. Because of the large system sizes involved, for
these calculations we used a PB solver, the APBS program (26), which was
designed to deal with large systems. The single monomer and all its replicas
had a single conformation, taken to be the structure of RNase Sa at the start of
constant-pH MD simulations.
In all PB calculations, the ion exclusion radius was 2 A˚, and the tem-
perature was 300 K. Solute atoms were assigned Bondi radii (42) and
AMBER94 partial charges (43), except for the charge modiﬁcation on the
C-terminal of pentapeptides at pH 1, as described above.
Nonpolar and polar surface areas of side chains
For modeling both the effects of point mutations on protein solubility and the
variation of octanol-to-water transfer free energies among AcWL-X-LL
peptides, the nonelectrostatic component was based on the areas of the
nonpolar and polar portions of the solvent-accessible surface calculated on
the side chain of a particular residue (the residue under mutation or the guest
residue). Values for Anp and Ap in this study were taken directly fromWimley
et al. (38) (as listed under the heading ‘‘ASA of X in AcWL-X-LL (A˚2)’’ in
their Table 1).
FIGURE 2 (A) Crystalline phase of RNase Sa, and (B) its
modeling as an effective dielectric medium. In the crystal-
line phase, a single RNase Sa monomer, shown in red, is
surrounded by its crystalline replicas. The space between
the replicas is ﬁlled by water. In the implicit model for the
crystalline phase, the inhomogeneous environment of the
red monomer is approximated by a uniform dielectric
medium (depicted by the blue ‘‘cloud’’), with a dielectric
constant intermediate between a high value for water and a
low value expected for protein molecules. The red mono-
mer is the solute, which is always assigned a low dielectric
constant (speciﬁcally, 4).
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RESULTS
pH dependence of RNase Sa solubility
The pH affects the protonation/deprotonation of titratable
groups in a protein. We sampled the protonation states by
running constant-pH MD simulations. At each pH, confor-
mations with different protonation states were selected, and
the electrostatic component, DGc/sel ; of the transfer free en-
ergy from the condensed phase to the solution phase was
calculated as the average over the selected conformations.
The pH dependence of protein solubility was then predicted
from
kBT ln½SðpHÞ=SðpHrefÞ ¼ ½DGc/sel ðpHÞ  DGc/sel ðpHrefÞ;
(6)
where S(pH) and DGc/sel ðpHÞ; respectively, are the solubility
and electrostatic component of DGc/s at a given pH, and
pHref is a reference pH. Equation 6 is derived from Eq. 2 by
assuming that the nonelectrostatic component of DGc/sne is
not affected by pH. The electrostatic free energy of the
protein in either phase consists of the Coulomb term and the
solvation term (see Eq. 4). In our calculations, each confor-
mation with a particular set of protonation states was used for
both the solution phase and the condensed phase. Therefore,
the Coulomb contributions of each conformation in the two
phases were identical, and only the difference in solvation
energy contributed to DGc/sel :
Generally, the electrostatic solvation energy of a protein in
the solution phase increases in magnitude with the increasing
magnitude of the net charge on the protein. A similar trend is
expected in the condensed phase, except that the magnitude
of the electrostatic solvation energy is reduced relative to its
counterpart in the solution phase (under the assumption that
the solvent dielectric constant in the condensed phase is
lower than in the solution phase). Taken together, DGc/sel is
expected to increase in magnitude with an increasing mag-
nitude of the net charge on the protein. The net charge can be
changed by varying the pH. At the pI, the net charge on the
protein is zero. As pH moves away from the pI in either di-
rection, the net charge increases in magnitude. Therefore, the
pH dependence of DGc/sel is expected to have a bell shape,
with the maximum occurring around the pI. Correspondingly
(see Eq. 6), the pH dependence of lnS should follow an in-
verted bell shape, as is usually observed (1,12,14,36,37).
The RNase Sa has a total of 12 carboxyl side chains and
two histidines (Fig. 1 A). Its isoelectric point is 3.5 (14). Our
results for the pH dependence of DGc/sel obtained in RNase
Sa conform to the expected bell shape. By allowing the
carboxyl side chains and histidines to titrate in the constant-
pH MD simulations, the solubility data of Shaw et al. (14) in
the pH range of 2.3–5.4 can be quantitatively rationalized by
our calculation, when the solvent dielectric constant of the
condensed phase is assigned to 55. That value is to be
compared with the value of 78.5 for the solution phase. (Note
that, in calculating the electrostatic solvation energy in either
the condensed phase or the solution phase, the dielectric
constant of the protein solute was kept at 4.) As Fig. 3 shows,
the overall experimental pH dependence of lnS is well-
reproduced by our calculation. Our calculation underesti-
mated lnS at the lowest pH value (2.3), probably because we
did not allow for the side chain of the N-terminal residue
(which happens to be an aspartate) and the C-terminal car-
boxyl to titrate because of a limitation in the AMBER
package that we used for constant-pH MD simulations.
We also performed a similar calculation with a solvent
dielectric constant of 60 assigned to the condensed phase.
The results did not differ signiﬁcantly from those shown in
Fig. 3 (with the root mean-square deviation between the
calculation and the experiment changing from 0.18 to 0.22
kcal/mol). Our calculations thus suggest that the dielectric
property of the condensed phase can be modeled with a
solvent dielectric constant in the range of 55–60.
pH dependence of insulin solubility
In addition to the ﬁve titratable groups shown in Fig. 1 B,
each monomer contains one arginine and one lysine (R22 and
K29, both on chain B), and shares one third of a bound zinc
ion. The pI of insulin would be expected to occur at a pH
where H5 is still protonated, but the four glutamates have
nearly completed deprotonation. The pI of insulin in our
modeled structure is thus expected to be;6, which is just the
result obtained from the constant-pH MD simulations. Ex-
perimentally, the pI of zinc-insulin is determined between 5–
5.5 (12,36,37). We attribute the discrepancy of;0.75 in pI to
anion binding, which is known to occur (36). We did not
model anion binding explicitly, but to account crudely for its
effect, we moved the nominal pH downward by 0.75 units
when comparing our calculated pH dependence of insulin
solubility against experimental data.
Fig. 4 shows this comparison. Below pH 5, our calcula-
tions are in good agreement with the results from three ex-
FIGURE 3 Comparison of calculated and experimental results for the pH
dependence of the solubility of RNase Sa.
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perimental studies (12,36,37). Above pH 5, the experimental
results themselves differ signiﬁcantly. Our calculations ex-
hibit an increase in solubility with increasing pH, as seen in
the experimental studies. In the calculations, the solvent di-
electric constant of the condensed phase was again set to 55.
Effective dielectric constant of the
condensed phase
In solubility measurements, the condensed phase is either
crystalline or amorphous (11). In a strict thermodynamic
sense, solubility is deﬁned with respect to a crystalline con-
densed phase. (The solubility measurements of Trevino et al.
(10) for RNase Sa were performed in the presence of an
amorphous condensed phase that presumably features irreg-
ularly arranged RNase Sa monomers instead of a regular
array, as found in a crystalline phase. See Trevino et al. (11)
for a discussion of the subtle differences between amorphous
and crystalline condensed phases.) We generated the crys-
talline phase of RNase Sa by replicating a single monomer to
a crystalline array (Fig. 2 A). We then calculated the elec-
trostatic solvation energy,Gcsolv; of the single monomer in the
background of the crystalline replicas. In this calculation, the
single monomer and all its replicas were assigned the low
dielectric constant of 4, and the space between replicas,
which should be ﬁlled with water, was assigned the high
dielectric constant of water (i.e., 78.5). Fig. 5 A shows that
Gcsolv reaches its plateau value when;100 replicas around the
single monomer are included. The plateau value can be taken
as the value of Gcsolv for a single monomer in an inﬁnite
crystalline array.
The inﬁnite array of crystalline replicas embedded in water
presents an inhomogeneous dielectric environment for the
single monomer. In our model of the condensed phase, this
inhomogeneous environment was replaced by a uniform di-
electric medium, with an effective dielectric constant ec. The
value of ec can be directly determined by matching the
electrostatic solvation energy for a single monomer inside
this uniform dielectric medium with the corresponding value,
Gcsolv; as determined above in the crystalline array. Fig. 5 B
shows that Gcsolv is reproduced with ec ; 53.5. This result
demonstrates that the solvent dielectric constant of 55, as
used above for calculating the pH dependence of protein
solubility, is not merely a result of ﬁtting experimental data,
but has a solid physical basis.
FIGURE 4 Comparison of calculated and experimental results for the pH
dependence of the solubility of insulin. The pH values of the calculated
results were shifted downward by 0.75 units to account for anion binding.
The experimental results of Desbuquois and Aurbach (37) and Fischel-
Ghodsian et al. (12) were for porcine insulin, whereas those of Fredericq and
Neurath (36) were for bovine insulin. The two species differ at only two
positions, involving uncharged residues, in sequence. Our calculations used
the structure of porcine insulin.
FIGURE 5 (A) Electrostatic solvation energy, Gcsolv; of a single RNase Sa
monomer in the presence of a crystalline array of replicas. The replicas serve
to change the dielectric environment of the single monomer. The inﬁnite
array is approached by including more and more distant replicas (n ¼ total
number of replicas included). The dashed curve through the data points
provides guidance for the eye. (B) Reproduction of Gcsolv when the inho-
mogeneous dielectric environment is replaced by a uniform dielectric me-
dium. The effective dielectric constant, ec, of the uniform dielectric medium
is varied to match Gcsolv; as indicated by the horizontal line.
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Effects of mutating residue T76
Trevino et al. (10) measured the changes in solubility of
RNase Sa at pH 4.25 when residue T76 was mutated into the
19 other types of amino acids. We modeled the point muta-
tions by accounting for their effects on both the electrostatic
and nonelectrostatic components of the transfer free energy
DGc/s. The mutational effect, DDGc/sel ðT/XÞ; on the
electrostatic component was obtained by calculating twice
the change in electrostatic solvation energy from the con-
densed phase to the solution phase (once for the wild-type
protein, and once for the mutant), and then taking the dif-
ference. The mutational effect DDGc/sne ðT/XÞ on the non-
electrostatic component was assumed to have the form
DDG
c/s
ne ðT/XÞ ¼ Dsc/snp ½AnpðXÞ  AnpðTÞ
1Dsc/sp ½ApðXÞ  ApðTÞ; (7)
where Anp(X) and Ap(X) are the areas of the nonpolar and
polar portions, respectively, of the solvent-accessible surface
calculated over the side chain of residue X, and Dsc/snp and
Dsc/sp ; respectively, are nonpolar and polar solvation pa-
rameters for the transfer of a solute from the condensed phase
to the solution phase. From DDGc/sel ðT/XÞ and DDGc/sne
ðT/XÞ; we predicted the relative solubility, S(X)/S(T), of
the mutant in reference to the wild-type protein from
kBT ln½SðXÞ=SðTÞ ¼ DDGc/sel ðT/XÞ1DDGc/sne ðT/XÞ:
(8)
Strong support for our approach to modeling mutational
effects is given by simply examining the ordering of the
solubility levels of the 20 RNase Sa variants, each with a
different amino acid occupying position 76. As Fig. 6 shows,
the solubility levels are high when position 76 is occupied by
charged amino acids (D, E, R, and K), moderate when oc-
cupied by polar amino acids (H, N, Q, and T), and low when
occupied by nonpolar amino acids (M, V, L, I, Y, F, and W).
Initially, we performed a multilinear regression of the exper-
imental data for kBTln[S(X)/S(T)] against DDGc/sel (T/X),
Anp(X) – Anp(T), and Ap(X) – Ap(T). The correlation R
2 of this
analysis is 0.83. The coefﬁcient of the DDGc/sel ðT/XÞ term
was found to be very close to 1, without further adjusting the
value (at 55) of the dielectric constant of the implicit solvent
modeling the condensed phase. This ﬁnding offers solid
validation for our treatment of the condensed phase as an
effective dielectric medium in calculating the electrostatic
component of transfer free energy.
By adjusting Dsc/snp and Ds
c/s
p ; Eqs. 7 and 8 were found
to reproduce well the experimental data for the variation of
the solubility of RNase Sa when T76 is replaced by the 19
other types of amino acids. As Fig. 6 shows, the results of the
calculation correctly rank the D and E variants as having the
highest solubility levels, and the F and W variants as having
the lowest solubility levels. In addition, variants with mea-
sured solubility levels either higher or lower than the T var-
iant are all correctly ranked as such by the calculation.
Trevino et al. (10) observed that there is a good correlation
between solubility and hydrophobicity for some of the vari-
ants with nonpolar residues occupying position 76. By
combining the electrostatic component with the non-
electrostatic component, as modeled based on polar and
nonpolar surface areas, we show here that the variation in
solubility among all 20 RNase Sa variants can be qualita-
tively rationalized. The optimized values of the adjustable
parameters Dsc/snp and Ds
c/s
p were 8.6 and 1.1 cal/mol/A˚
2,
respectively.
Trevino et al. (10) also measured the changes in solubility
of RNase Sa at pH 7 when residue T76 was mutated into the
ﬁve other types of amino acids: D, S, A, K, and R. We used
this set of data as an important check for our approach. By
repeating the calculations for mutational effects at pH 7
without further adjustment of any parameters, the solubility
levels of the D, S, A, K, and R mutants were calculated to be
196, 61, 45, 23, and 28 g/L (on the basis of a solubility level
of 41 g/L for the wild-type protein). These values can be
compared with the experimental results of 160, 130, 92, 60,
and 50 g/L. Our calculations correctly predict that the D and S
mutants are more soluble than the A mutant, whereas the K
and R mutants are less soluble.
Octanol-to-water transfer free energies
of pentapeptides
We calculated the octanol-to-water transfer free energies,
DGo/w, of the pentapeptides AcWL-X-LL in nearly the
same way that we modeled the effects of point mutations on
the solubility of RNase Sa. Speciﬁcally, DGo/w was as-
sumed to consist of an electrostatic component DGo/wel and a
nonelectrostatic componentDGo/wne :We obtainedDG
o/w
el as
the difference in electrostatic solvation energy between two
FIGURE 6 Comparison of calculated and experimental results for the
variation of solubility among 20 RNase Sa variants with point mutations at
position 76. The calculated results for T76 are shown in lighter shades to
indicate the wild-type protein.
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implicit solvents: one modeling water with a dielectric con-
stant of 78.5, and one modeling octanol with an adjustable
dielectric constant (see below). The variation of DGo/wne
among the 20 pentapeptides was based on the nonpolar and
polar portions of the solvent-accessible surface areas, cal-
culated over the side chain of guest residue X:
DGo/wne ¼ Dso/wnp AnpðXÞ1Dso/wp ApðXÞ1DGo/wne0 ; (9)
where DGo/wne0 represents the contribution of the common
moiety of the 20 pentapeptides to the nonelectrostatic com-
ponent of the transfer free energy.
The dielectric constant of the octanol solvent was adjusted
so that a multilinear regression of the experimental data of
Wimley et al. (38) for DGo/w (at pH 9) against DGo/wel ;
Anp(X), and Ap(X) resulted in a unity coefﬁcient for the
DGo/wel term. The unit coefﬁcient was achieved when a di-
electric constant of 15 was assigned to the octanol solvent,
with the regression analysis reaching a correlation R2 of 0.91.
Wimley et al. (38) performed regression analysis against
Anp(X) and Ap(X) by restricting X to amino acids with non-
polar side chains. Our analysis, incorporating the electrostatic
component, accounts for the variation of DGo/w among all
20 types of amino acids (Fig. 7). The resulting values of the
nonpolar and polar solvation parameters Dso/wnp and Ds
o/w
p
for the octanol-to-water transfer are 18.1 and 13.5 cal/mol/A˚2,
respectively.
Wimley et al. (38) also obtained octanol-to-water transfer
free energies for nine of the 20 pentapeptides (with guest
residues D, E, A, G, S, T, H, K, and R) at pH 1. We modeled
the decrease from pH 9 to pH 1 by recalculating the elec-
trostatic component DGo/wel ; this time with all carboxyl
groups and the histidine side chain protonated. The experi-
mental data for the change in octanol-to-water transfer free
energy from pH 9 to pH 1 were reasonably well-reproduced
by DGo/wel ðpH 1Þ  DGo/wel ðpH 9Þ 1 3 kcal/mol. It is not
clear why a constant offset of 3 kcal/mol was required to ﬁt
the experimental data. Possible reasons include potential
differences in experimental conditions at the two pH values,
and neglect of pH-dependent conformational changes in our
calculations.
DISCUSSION
We present a computational approach for predicting relative
solubility. The power of this approach was demonstrated
by quantitative rationalization of experimental results for
the effects of pH and point mutations on protein solubility.
The basic tenet of the approach involves the modeling of the
condensed phase as an implicit solvent. As a result, the cal-
culation of solubility becomes equivalent to the calculation of
transfer free energy. The treatment of pH effects presented
here, along with a previous computational study of salt ef-
fects (20), shows that solvent conditions can be quantitatively
modeled. Physics-based computations thus open a new av-
enue for determining the dependence of protein solubility on
solvent conditions, and for investigating optimal protein
crystallization conditions. Likewise, our modeling of muta-
tional effects on protein solubility demonstrates the ability to
predict the contributions of individual residues to protein
solubility. This ability has a potentially signiﬁcant impact on
the selection of protein targets in structural genomics pro-
jects, and on the design of therapies for diseases associated
with protein aggregation.
Our calculation of protein solubility was performed in
parallel with a calculation of octanol-to-water transfer free
energies of peptides. This parallel study underscores the basic
tenet of our approach, which involves the modeling of the
condensed phase as an implicit solvent. Our results for pro-
tein solubility conﬁrm that the condensed phase is amenable
to such modeling. Transfer free energies of small solutes are
widely used for parameterizing solvation models. Such data
are difﬁcult to obtain for proteins but are highly desirable,
because there is evidence that the parameterization of sol-
vation models may be sensitive to solute size (44). Our study
suggests that protein solubility data can serve the role of
transfer free energies for parameterizing solvation models for
proteins.
Our expectation for the condensed phase as an implicit
solvent is that its properties are intermediate between those of
water and organic solvents. This expectation is matched by
the values of the dielectric constant and nonelectrostatic
solvation parameters required to reproduce experimental data
on protein solubility. A calculation of the electrostatic sol-
vation energy of RNase Sa in the crystalline condensed phase
speciﬁcally conﬁrms the value;55 for the dielectric constant
when the condensed phase is modeled as a uniform dielectric
medium. Although that calculation was for RNase Sa, a
solvent dielectric constant of 55 for the condensed phase is
70% of the value for water. This percentage is close to the
water content in many protein crystals. The nonelectrostatic
FIGURE 7 Comparison of calculated and experimental results for the
octanol-to-water transfer free energies of pentapeptides AcWL-X-LL. The
identity of the guest residue X is shown on the horizontal axis.
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solvation parameters, Dsc/snp and Ds
c/s
p ; also have values
(8.6 and 1.1 cal/mol/A˚2, respectively) lower than those for the
transfer from octanol to water (18.1 and 13.5 cal/mol/A˚2,
respectively).
A number of details in our treatment of electrostatic and
nonelectrostatic contributions can be improved. For example,
in our electrostatic calculations, the solute charges were ﬁxed
upon transferring from one phase to another, or from one
solvent to another. In reality, electronic polarization of the
solute can be different in different solvent environments. A
neglect of solute electronic polarization may partly explain
why a dielectric constant of 15 was required to model the
octanol solvent, which is known to have a dielectric constant
of 10.3. (In this context, the interpretation of the value of 55
for the dielectric constant of the condensed phase is also
subject to the error caused by the neglect of solute electronic
polarization.) Likewise, our treatment of the nonelectrostatic
component relied on the use of nonpolar and polar accessible
surface areas. More sophisticated formulations were pro-
posed (32,34,35). Protein solubility data, coupled with im-
proved treatments of electrostatic and nonelectrostatic
contributions, hold the promise of leading to better solvation
models.
Finally, our modeling of such a complex environment as
the condensed phase in terms of a simple implicit solvent may
prove inspiring for the modeling of other complex environ-
ments, such as the crowded milieu inside cells. Such mod-
eling will move computational studies of biomolecules closer
to physiological conditions.
This work was supported in part by grant GM058187 from the National
Institutes of Health.
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